Pages Menu
Categories Menu

Sanofi Genzyme Advisory Board Opportunity

Sanofi Genzyme Advisory Board Opportunity

NNPDF has been asked to share information to determine if you are eligible to participate in a virtual advisory board. Sanofi Genzyme will be conducting a patient advisory board with the purpose to allow Sanofi Genzyme the opportunity to hear from community members about their experience living with or caring for someone currently living with ASMD. Sanofi Genzyme hopes to learn more about the ASMD journey and potential treatment decisions.

Criteria for participation if you are selected as a member of the Advisory Board:

  • The advisory board will be conducted virtually via Zoom, in 2 sessions the week of February 15, 2021.
  • Participants would need access to reliable internet, with solid video and audio connection, on a laptop or desktop. (no mobile phone connection and prefer no iPad)
  • Session will be moderated by a third-party agency and will include some members of the Sanofi Genzyme Team.
  • Participants will be asked to actively share opinions, feelings, and reactions during the discussion. You cannot be shy and must be comfortable speaking up! 
  • Participants must be respectful of the various participants experiences and opinions.
  • Participants will be compensated for their time and will need to sign certain agreements and waivers.
  • The advisory board is limited to US residents only.

RSVP deadline is November 30, 2020.

Click here to apply.